BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 11181570)

  • 1. Increased tumour risk for BWS patients correlates with aberrant H19 and not KCNQ1OT1 methylation: occurrence of KCNQ1OT1 hypomethylation in familial cases of BWS.
    Bliek J; Maas SM; Ruijter JM; Hennekam RC; Alders M; Westerveld A; Mannens MM
    Hum Mol Genet; 2001 Mar; 10(5):467-76. PubMed ID: 11181570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the methylation status of the KCNQ1OT and H19 genes in leukocyte DNA for the diagnosis and prognosis of Beckwith-Wiedemann syndrome.
    Gaston V; Le Bouc Y; Soupre V; Burglen L; Donadieu J; Oro H; Audry G; Vazquez MP; Gicquel C
    Eur J Hum Genet; 2001 Jun; 9(6):409-18. PubMed ID: 11436121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor development in the Beckwith-Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1OT1.
    Weksberg R; Nishikawa J; Caluseriu O; Fei YL; Shuman C; Wei C; Steele L; Cameron J; Smith A; Ambus I; Li M; Ray PN; Sadowski P; Squire J
    Hum Mol Genet; 2001 Dec; 10(26):2989-3000. PubMed ID: 11751681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenotype-phenotype correlations in Beckwith-Wiedemann syndrome.
    Engel JR; Smallwood A; Harper A; Higgins MJ; Oshimura M; Reik W; Schofield PN; Maher ER
    J Med Genet; 2000 Dec; 37(12):921-6. PubMed ID: 11106355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relaxation of insulin-like growth factor 2 imprinting and discordant methylation at KvDMR1 in two first cousins affected by Beckwith-Wiedemann and Klippel-Trenaunay-Weber syndromes.
    Sperandeo MP; Ungaro P; Vernucci M; Pedone PV; Cerrato F; Perone L; Casola S; Cubellis MV; Bruni CB; Andria G; Sebastio G; Riccio A
    Am J Hum Genet; 2000 Mar; 66(3):841-7. PubMed ID: 10712200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects.
    DeBaun MR; Niemitz EL; McNeil DE; Brandenburg SA; Lee MP; Feinberg AP
    Am J Hum Genet; 2002 Mar; 70(3):604-11. PubMed ID: 11813134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of KCNQ1OT1, CDKN1C, H19, and PLAGL1 and the methylation patterns at the KvDMR1 and H19/IGF2 imprinting control regions is conserved between human and bovine.
    Robbins KM; Chen Z; Wells KD; Rivera RM
    J Biomed Sci; 2012 Nov; 19(1):95. PubMed ID: 23153226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic modification and uniparental inheritance of H19 in Beckwith-Wiedemann syndrome.
    Catchpoole D; Lam WW; Valler D; Temple IK; Joyce JA; Reik W; Schofield PN; Maher ER
    J Med Genet; 1997 May; 34(5):353-9. PubMed ID: 9152830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beckwith-Wiedemann syndrome.
    Choufani S; Shuman C; Weksberg R
    Am J Med Genet C Semin Med Genet; 2010 Aug; 154C(3):343-54. PubMed ID: 20803657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A maternally methylated CpG island in KvLQT1 is associated with an antisense paternal transcript and loss of imprinting in Beckwith-Wiedemann syndrome.
    Smilinich NJ; Day CD; Fitzpatrick GV; Caldwell GM; Lossie AC; Cooper PR; Smallwood AC; Joyce JA; Schofield PN; Reik W; Nicholls RD; Weksberg R; Driscoll DJ; Maher ER; Shows TB; Higgins MJ
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):8064-9. PubMed ID: 10393948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epigenetic imprinting defect of patients with Beckwith-Wiedemann syndrome born after assisted reproductive technology is not restricted to the 11p15 region.
    Rossignol S; Steunou V; Chalas C; Kerjean A; Rigolet M; Viegas-Pequignot E; Jouannet P; Le Bouc Y; Gicquel C
    J Med Genet; 2006 Dec; 43(12):902-7. PubMed ID: 16825435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paradoxical NSD1 mutations in Beckwith-Wiedemann syndrome and 11p15 anomalies in Sotos syndrome.
    Baujat G; Rio M; Rossignol S; Sanlaville D; Lyonnet S; Le Merrer M; Munnich A; Gicquel C; Cormier-Daire V; Colleaux L
    Am J Hum Genet; 2004 Apr; 74(4):715-20. PubMed ID: 14997421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low frequency of p57KIP2 mutation in Beckwith-Wiedemann syndrome.
    Lee MP; DeBaun M; Randhawa G; Reichard BA; Elledge SJ; Feinberg AP
    Am J Hum Genet; 1997 Aug; 61(2):304-9. PubMed ID: 9311734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular subtypes and phenotypic expression of Beckwith-Wiedemann syndrome.
    Cooper WN; Luharia A; Evans GA; Raza H; Haire AC; Grundy R; Bowdin SC; Riccio A; Sebastio G; Bliek J; Schofield PN; Reik W; Macdonald F; Maher ER
    Eur J Hum Genet; 2005 Sep; 13(9):1025-32. PubMed ID: 15999116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor risk in Beckwith-Wiedemann syndrome: A review and meta-analysis.
    Rump P; Zeegers MP; van Essen AJ
    Am J Med Genet A; 2005 Jul; 136(1):95-104. PubMed ID: 15887271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imprinting status of 11p15 genes in Beckwith-Wiedemann syndrome patients with CDKN1C mutations.
    Li M; Squire J; Shuman C; Fei YL; Atkin J; Pauli R; Smith A; Nishikawa J; Chitayat D; Weksberg R
    Genomics; 2001 Jun; 74(3):370-6. PubMed ID: 11414765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of imprinting of a paternally expressed transcript, with antisense orientation to KVLQT1, occurs frequently in Beckwith-Wiedemann syndrome and is independent of insulin-like growth factor II imprinting.
    Lee MP; DeBaun MR; Mitsuya K; Galonek HL; Brandenburg S; Oshimura M; Feinberg AP
    Proc Natl Acad Sci U S A; 1999 Apr; 96(9):5203-8. PubMed ID: 10220444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paternal 132 bp deletion affecting
    Eggermann T; Kraft F; Lausberg E; Ergezinger K; Kunstmann E
    J Med Genet; 2021 Mar; 58(3):173-176. PubMed ID: 32447323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenotyping as a tool for the prediction of tumor risk and tumor type in patients with Beckwith-Wiedemann syndrome (BWS).
    Bliek J; Gicquel C; Maas S; Gaston V; Le Bouc Y; Mannens M
    J Pediatr; 2004 Dec; 145(6):796-9. PubMed ID: 15580204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beckwith-Wiedemann syndrome with long QT caused by a deletion involving KCNQ1 but not KCNQ1OT1:TSS-DMR.
    Urakawa T; Ozawa J; Tanaka M; Narusawa H; Matsuoka K; Fukami M; Nagasaki K; Kagami M
    Eur J Med Genet; 2023 Jan; 66(1):104671. PubMed ID: 36402267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.